Guidelines for the prevention and management of cardiovascular disease associated with fine dust/Asian dust exposure.
10.5124/jkma.2015.58.11.1044
- Author:
In Soo KIM
1
;
Ji Yong JANG
;
Tae Hoon KIM
;
Junbeom PARK
;
Jaemin SHIM
;
Jin Bae KIM
;
Young Sup BYUN
;
Jung Hoon SUNG
;
Young Won YOON
;
Jong Youn KIM
;
Yang Je CHO
;
Changsoo KIM
;
Boyoung JOUNG
Author Information
1. Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. cby6908@yuhs.ac
- Publication Type:Original Article
- Keywords:
Air pollution;
Particulate matter;
Yellow dust;
Cardiovascular diseases
- MeSH:
Air Pollution;
Arrhythmias, Cardiac;
Atherosclerosis;
Cardiovascular Diseases*;
Delivery of Health Care;
Dust*;
Epidemiologic Studies;
Mortality;
Particulate Matter;
Writing
- From:Journal of the Korean Medical Association
2015;58(11):1044-1059
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Epidemiological studies have demonstrated an increased risk for cardiovascular events in relation to both short- and long-term exposure to ambient particulate matter (PM). Several plausible mechanistic pathways have been described, including an enhanced propensity for arrhythmias, systemic inflammatory responses, and the chronic promotion of atherosclerosis. On the basis of this review, several new findings were reached, including the following: exposure to PM including PM <2.5 microm in diameter can trigger cardiovascular disease-related mortality; longer-term exposure (e.g., a few years) increases the risk for cardiovascular mortality; reductions in PM levels are associated with decreases in cardiovascular mortality within a period as short as a few years; and many credible pathological mechanisms have been elucidated that lend biological plausibility to these findings. It is the opinion of the writing group that the overall evidence is consistent with a causal relationship between PM exposure and cardiovascular morbidity and mortality. Finally, PM exposure is deemed a modifiable factor that contributes to cardiovascular morbidity and mortality. The purpose of this statement is to develop evidence-based practical guidelines for healthcare professionals and regulatory agencies with a comprehensive review of the literature on air pollution and cardiovascular disease and a specific focus on the clinical implications.
